Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Poole

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
European Journal of Pain (London, England)|March 29, 2008
Role of cytokines in mediating mechanical hypernociception in a model of delayed-type hypersensitivity in miceThiago M Cunha, Waldiceu A Verri, Daniel A Valério, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 6, 2009
Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic painLisa C Loram, Jacqueline A Harrison, Evan M Sloane, et al.
Human Molecular Genetics|December 18, 2009
Genetic modifiers of abnormal organelle biogenesis in a Drosophila model of BLOC-1 deficiencyVerónica T Cheli, Richard W Daniels, Ruth Godoy, et al.
The Lancet. Respiratory Medicine|October 11, 2020
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled studyNathan J Brendish, Stephen Poole, Vasanth V Naidu, et al.
Pharmaceutical Research|March 13, 2010
Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administrationRyan Gene Soderquist, Evan M Sloane, Lisa C Loram, et al.
Brain, Behavior, and Immunity|July 5, 2008
Proinflammatory cytokines oppose opioid-induced acute and chronic analgesiaMark R Hutchinson, Benjamen D Coats, Susannah S Lewis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
"Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeuticsRichard Stebbings, Lucy Findlay, Cherry Edwards, et al.
Journal of Immunological Methods|August 8, 2012
Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical useMark B Pepys, J Ruth Gallimore, Joanne Lloyd, et al.
The Journal of Infection|October 4, 2021
A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countriesMaria Victoria Humbert, Precious Chinonyerem Opurum, Nathan J Brendish, et al.
Molecular Neurodegeneration|January 20, 2016
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's diseaseNour K Majbour, Nishant N Vaikath, Karin D van Dijk, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
European Journal of Pain (London, England)|March 29, 2008
Role of cytokines in mediating mechanical hypernociception in a model of delayed-type hypersensitivity in miceThiago M Cunha, Waldiceu A Verri, Daniel A Valério, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 6, 2009
Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic painLisa C Loram, Jacqueline A Harrison, Evan M Sloane, et al.
Human Molecular Genetics|December 18, 2009
Genetic modifiers of abnormal organelle biogenesis in a Drosophila model of BLOC-1 deficiencyVerónica T Cheli, Richard W Daniels, Ruth Godoy, et al.
The Lancet. Respiratory Medicine|October 11, 2020
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled studyNathan J Brendish, Stephen Poole, Vasanth V Naidu, et al.
Pharmaceutical Research|March 13, 2010
Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administrationRyan Gene Soderquist, Evan M Sloane, Lisa C Loram, et al.
Brain, Behavior, and Immunity|July 5, 2008
Proinflammatory cytokines oppose opioid-induced acute and chronic analgesiaMark R Hutchinson, Benjamen D Coats, Susannah S Lewis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
"Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeuticsRichard Stebbings, Lucy Findlay, Cherry Edwards, et al.
Journal of Immunological Methods|August 8, 2012
Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical useMark B Pepys, J Ruth Gallimore, Joanne Lloyd, et al.
The Journal of Infection|October 4, 2021
A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countriesMaria Victoria Humbert, Precious Chinonyerem Opurum, Nathan J Brendish, et al.
Molecular Neurodegeneration|January 20, 2016
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's diseaseNour K Majbour, Nishant N Vaikath, Karin D van Dijk, et al.
Pageof 9